Multimodal complex treatment in a subgroup of patients with vertebral pain syndroms

Phase 4

• Conditions: M40-M54; Dorsopathies

• Registration Number: DRKS00011492
• Lead Sponsor: ANOA – Krankenhaus GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2016-01-20
• Study Start: 2017-01-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 276

Inclusion Criteria

musculoskeletal vertebral pain syndrome
with or without spread pain
presence of disorders on at least two levels:

complex functional findings, e.g.
- linkages and / or
- coordination disorders and / or
- disorders of the posture / motion stabilization
- vegetative disorders

morphological disorders, e.g.
- degenerative changes in the spine
- intervertebral disc disorders
- spinal stenosis

psychosocial factors, e.g.
- dysfunctional illness cognitions and behaviors
- psychosocial influences on pain development

Exclusion Criteria

pain syndrome on the basis of advanced arthrosis with absolute surgical indication
neurological system diseases
rheumatic / inflammatory diseases
tumor diseases
pain on internist basis
mental disorders as secondary diagnoses and psychosocial influences, if there is a highly significant influence on the development of the disease
neurological deficits symptoms (radicular syndrome) with absolute surgical indication
polyneuropathies
pregnancy, lactation
severe cardiopulmonary insufficiency (NYHA III and IV)
mental illness as the main diagnosis, including F45.40 and F45.41
running pension process

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
pain intensity (aktual pain intensity, worst pain, average pain, mean of the pain intensity)<br>(v. Korff-- Graded chronic pain status)<br><br>The data were collected at the following measuring time points (MTP): T1 (before the intervention / baseline), T2 (end of intervention), T3 (6 months after the end of the intervention) and T4 (12 months after the end of the intervention).

Secondary Outcome Measures

Name	Time	Method
Quality of life:<br>SF 12<br><br>functionality: <br>Oswestry Disability Index<br>Pain Disability Index<br><br>psychometry:<br>HADS-D<br>FF-Stabs<br><br>Die Datenerhebung erfolgte an den folgenden Messzeitpunkte (MZP): <br>T1: vor der Intervention, T2: am Ende der Intervention, T3: 6 Monate nach Interventionsende, T4: 12 Monate nach Interventionsende